Han, Liyuan
Zhang, Tao
You, Dingyun
Chen, Wei
Bray, George
Sacks, Frank
Qi, Lu
Clinical trials referenced in this document:
Documents that mention this clinical trial
Starch Digestion–Related Amylase Genetic Variant Affects 2-Year Changes in Adiposity in Response to Weight-Loss Diets: The POUNDS Lost Trial
https://doi.org/10.2337/db16-1482
Starch Digestion–Related Amylase Genetic Variants, Diet, and Changes in Adiposity: Analyses in Prospective Cohort Studies and a Randomized Dietary Intervention (Results)
https://doi.org/10.2337/db19-1257
Macronutrient Intake–Associated <i>FGF21</i> Genotype Modifies Effects of Weight-Loss Diets on 2-Year Changes of Central Adiposity and Body Composition: The POUNDS Lost Trial
https://doi.org/10.2337/dc16-1111
Temporal and mediation relations of weight loss, and changes in insulin resistance and blood pressure in response to 2-year weight-loss diet interventions: the POUNDS Lost trial
https://doi.org/10.1007/s00394-021-02643-8
Changes in Gut Microbiota–Related Metabolites and Long-term Successful Weight Loss in Response to Weight-Loss Diets: The POUNDS Lost Trial (Results)
https://doi.org/10.2337/dc17-2108
Circulating Gut Microbiota Metabolite Trimethylamine N-Oxide (TMAO) and Changes in Bone Density in Response to Weight Loss Diets: The POUNDS Lost Trial (Results)
https://doi.org/10.2337/dc19-0134
Gut microbiota metabolites, amino acid metabolites and improvements in insulin sensitivity and glucose metabolism: the POUNDS Lost trial
https://doi.org/10.1136/gutjnl-2018-316155
Funding for this research was provided by:
the Innovative Talent Support Plan of the Medical and Health Technology Project in Zhejiang Province (2021422878)
Ningbo Science and Technology Project (202002N3152)
Ningbo Health Branding Subject Fund (PPXK2018-02)
Sanming Project of Medicine in Shenzhen (SZSM201803080)
Article History
Received: 10 February 2021
Accepted: 16 July 2021
First Online: 28 July 2021
Declarations
:
: There are no conflicts of interest.